New drug BAT8006 tested in 216 patients with advanced cancers
NCT ID NCT05378737
First seen Jan 09, 2026 · Last updated Apr 29, 2026 · Updated 17 times
Summary
This early-stage study tested a new drug called BAT8006 in 216 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety, find the highest safe dose, and see how the drug moves through the body. This is not a cure but aims to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anhui Cancer Hospital
Hefei, Anhui, China
-
Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Beijing, Beijing Municipality, China
-
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center
Shenzhen, Guangdong, China
-
Fujian Cancer Hospital
Fuzhou, Fujian, China
-
Guangxi Medical University Cancer Hospital & Guangxi Cancer Institute
Nanning, Guangxi, China
-
Hubei Cancer Hospital
Wuhan, Hubei, China
-
Hunan Cancer Hospital
Changsha, Hunan, China
-
Liaoning Cancer Hospital&Institute
Shenyang, Liaoning, China
-
Shandong Cancer Hospital
Jinan, Shandong, China
-
Shanxi Provincial Cancer Hospital
Taiyuan, Shanxi, China
-
Sun Yat-Sen Memorlal Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
-
The First Hospital of Jilin University
Changchun, Jilin, China
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China
-
Tongji Hospital, Tongji Medical College of Hust
Wuhan, Hubei, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
-
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
Conditions
Explore the condition pages connected to this study.